PF-06282999
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-06282999, covering 2013-03-13 to 2013-07-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy Adults [Phase 1]